Vistance Networks (VISN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 consolidated net sales were $1.39 billion, down 12.7%–13% year-over-year, with core net sales at $1.05 billion, down 17% due to lower demand and customer inventory corrections.
Adjusted EBITDA rose 19.5%–20% to $302 million, with adjusted EPS doubling to $0.34 per share and net income turning positive at $28.2 million.
Core adjusted EBITDA was $201 million, with margin improving to 19.1% from 15.9% year-over-year.
Announced definitive agreement to sell OWN segment and DAS business to Amphenol for $2.1 billion, expected to close in H1 2025.
Completed Casa Systems asset acquisition for $45–$45.1 million, strengthening the ANS segment.
Financial highlights
CCS net sales grew 4.5%–5% year-over-year to $728 million, with adjusted EBITDA up 107% to $171 million and margin at 23.5%.
NICS (excluding DAS) net sales fell 44% to $132 million, with negative adjusted EBITDA due to lower RUCKUS demand and inventory write-offs.
ANS net sales dropped 42.5%–43% to $193 million, with adjusted EBITDA down 47% to $33 million.
Gross margin improved to 39.5% from 35.8% year-over-year.
Cash flow from operations was $51 million, adjusted free cash flow $68.7–$69 million, and quarter-end liquidity at $880–$881.3 million.
Outlook and guidance
Full-year 2024 core adjusted EBITDA guidance is $700–$800 million, with breakeven adjusted free cash flow expected.
Sequential core revenue and adjusted EBITDA improvement anticipated in Q3, but short-term demand in NICS and ANS remains uncertain.
Consolidated adjusted EBITDA outlook for 2024 is $1.0–$1.1 billion; adjusted free cash flow expected between $(25) million and $25 million.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025